Evaluation of Adjuvant Chemotherapy Survival Outcomes Among Patients With Surgically Resected Pancreatic Carcinoma With Node-Negative Disease After Neoadjuvant Therapy
Abdulrahman Y. Hammad(Medical College of Wisconsin), Amer H. Zureikat(University of Pittsburgh Medical Center), Susannah G. Ellsworth(University of Pittsburgh Medical Center), Samer AlMasri(University of Pittsburgh Medical Center), Susan Tsai(The Ohio State University Wexner Medical Center), Jacob C. Hodges(University of Pittsburgh Medical Center), Nathan Bahary(University of Pittsburgh Medical Center), Mohammed Aldakkak(Medical College of Wisconsin), Douglas B. Evans(The University of Texas MD Anderson Cancer Center), Kenneth K. Lee(University of Pittsburgh Medical Center), Alessandro Paniccia(University of Colorado Anschutz Medical Campus), Aatur D. Singhi(University of California, San Francisco)
Cited by 32
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
|BMC Cancer|2018|391
Population-Based Study of Islet Cell Carcinoma
|Annals of Surgical Oncology|2007|338
Plasma extracellular RNA profiles in healthy and cancer patients
|Scientific Reports|2016|294